Evaluation of oxidative stress levels in obesity and diabetes by the free oxygen radical test and free oxygen radical defence assays and correlations with anthropometric and laboratory parameters

Table 1 Demographic, clinical and biochemical parameters of the study population vs controls

	Obese subjects	Controls	P value
Male/Female (n)	21/81	9/21	0.3234
Age (yr)	62.14 (10.19)	44.60 (18.76)	< 0.0001
BMI (kg/m2)	35.75 (3.75)	24.56 (1.78)	< 0.0001
WC (cm)	106.58 (13.27)	96.38 (3.76)	< 0.0001
FPG (mg/dL)	117.56 (42.13)	92.63 (7.60)	0.0016
TC (mg/dL)	228.66 (45.22)	137.70 (20.46)	< 0.0001
HDL-c (mg/dL)	47.72 (12.68)	66.23 (10.85)	< 0.0001
LDL-c (mg/dL)	141.78 (42.43)	106.93 (15.93)	< 0.0001
TG (mg/dL)	156.98 (92.25)	95.77 (20.22)	0.0005
UA (mg/dL)	4.44 (1.18)	3.80 (0.92)	0.0073
eGFR (mL/min/1.73 m2)	68.49 (18.84)	106.77 (17.75)	< 0.0001
FORT (mmol/L H2O2)	3.04 (0.36)	2.03(0.14)	< 0.0001
FORD (mmol/L Trolox)	1.27 (0.13)	1.87 (1.20)	0.0072

Data are presented as mean ± SD or as n. BMI: Body mass index; WC: Waist circumference; FGP: Fasting plasma glucose; TC: Total cholesterol; HDL-c: High-density lipoprotein cholesterol; LDL-c: Low-density lipoprotein cholesterol; TG: Triglycerides; UA: Uric acid; eGFR: Estimated glomerular filtration rate; FORT: Free oxygen radical test; FORD: Free oxygen radical defence.